Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the Near trial
BACKGROUND: The aim of this study was to evaluate efficacy and toxicity of radioimmunotherapy with intensity-modulated radiation (IMRT) and cetuximab in stage III nonsmall cell lung cancer (NSCLC). METHODS: NEAR was a prospective, monocentric phase II trial including patients unfit for chemoradiatio...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 January 2011
|
| In: |
Cancer
Year: 2011, Jahrgang: 117, Heft: 13, Pages: 2986-2994 |
| ISSN: | 1097-0142 |
| DOI: | 10.1002/cncr.25888 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cncr.25888 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25888 
|
| Verfasserangaben: | Alexandra D. Jensen, Marc W. Münter, Helge G. Bischoff, Renate Haselmann, Uwe Haberkorn, Peter E. Huber, Michael Thomas, Jürgen Debus, and Klaus K. Herfarth |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1809113709 | ||
| 003 | DE-627 | ||
| 005 | 20250827111913.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220705s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cncr.25888 |2 doi | |
| 035 | |a (DE-627)1809113709 | ||
| 035 | |a (DE-599)KXP1809113709 | ||
| 035 | |a (OCoLC)1341461893 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jensen, Alexandra |d 1976- |e VerfasserIn |0 (DE-588)136129552 |0 (DE-627)577179020 |0 (DE-576)284704687 |4 aut | |
| 245 | 1 | 0 | |a Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab |b the Near trial |c Alexandra D. Jensen, Marc W. Münter, Helge G. Bischoff, Renate Haselmann, Uwe Haberkorn, Peter E. Huber, Michael Thomas, Jürgen Debus, and Klaus K. Herfarth |
| 264 | 1 | |c 24 January 2011 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.07.2022 | ||
| 520 | |a BACKGROUND: The aim of this study was to evaluate efficacy and toxicity of radioimmunotherapy with intensity-modulated radiation (IMRT) and cetuximab in stage III nonsmall cell lung cancer (NSCLC). METHODS: NEAR was a prospective, monocentric phase II trial including patients unfit for chemoradiation regimen; treatment consisted of IMRT and weekly cetuximab followed by a 13-week maintenance period. Primary endpoints were toxicity and feasibility; secondary endpoints were remission rates at completion of the planned treatment according to Response Evaluation Criteria In Solid Tumor (RECIST), local/distant progression-free survival, and overall survival. RESULTS: Thirty patients (median age, 71 years) were treated within the protocol. Overall response rate was 63% (partial remission: 19 of 30) patients. Median locoregional, distant, overall progression-free survival was 20.5, 10.9, and 8.5 months. Median overall survival was 19.5 months, with an estimated 1- and 2-year survival of 66.7% and 34.9% respectively. Stage (IIIA vs IIIB) and histologic subtype did not have a significant impact on survival rates in our patients. Treatment was tolerated well with only mild toxicity (°3 pneumonitis: 3.3%, any °3 acute toxicity: 36.7%). CONCLUSIONS: Combined radioimmunotherapy with cetuximab was safe and feasible, especially in elderly patients with multiple comorbidities. A more intensified regimen warranted investigation. | ||
| 650 | 4 | |a cetuximab | |
| 650 | 4 | |a elderly | |
| 650 | 4 | |a IMRT | |
| 650 | 4 | |a NSCLC | |
| 650 | 4 | |a radioimmunotherapy | |
| 700 | 1 | |a Münter, Marc |d 1972- |e VerfasserIn |0 (DE-588)121295591 |0 (DE-627)705363104 |0 (DE-576)292633645 |4 aut | |
| 700 | 1 | |a Bischoff, Helge |d 1958- |e VerfasserIn |0 (DE-588)111184576 |0 (DE-627)389658286 |0 (DE-576)167287249 |4 aut | |
| 700 | 1 | |a Haselmann, Renate |e VerfasserIn |0 (DE-588)1075341132 |0 (DE-627)833201700 |0 (DE-576)443408459 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Huber, Peter E. |d 1965- |e VerfasserIn |0 (DE-588)1074678869 |0 (DE-627)832350109 |0 (DE-576)442767803 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Herfarth, Klaus |e VerfasserIn |0 (DE-588)1032757582 |0 (DE-627)739273116 |0 (DE-576)171352289 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer |d New York, NY : Wiley-Liss, 1948 |g 117(2011), 13, Seite 2986-2994 |h Online-Ressource |w (DE-627)271350334 |w (DE-600)1479932-7 |w (DE-576)078590884 |x 1097-0142 |7 nnas |a Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab the Near trial |
| 773 | 1 | 8 | |g volume:117 |g year:2011 |g number:13 |g pages:2986-2994 |g extent:9 |a Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab the Near trial |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cncr.25888 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.25888 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220705 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1032757582 |a Herfarth, Klaus |m 1032757582:Herfarth, Klaus |d 910000 |d 911400 |d 50000 |e 910000PH1032757582 |e 911400PH1032757582 |e 50000PH1032757582 |k 0/910000/ |k 1/910000/911400/ |k 0/50000/ |p 9 |y j | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 8 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 50000 |e 50000PT1054438781 |k 0/50000/ |p 7 | ||
| 998 | |g 1074678869 |a Huber, Peter E. |m 1074678869:Huber, Peter E. |d 50000 |e 50000PH1074678869 |k 0/50000/ |p 6 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 1075341132 |a Haselmann, Renate |m 1075341132:Haselmann, Renate |d 910000 |d 911400 |e 910000PH1075341132 |e 911400PH1075341132 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 111184576 |a Bischoff, Helge |m 111184576:Bischoff, Helge |d 910000 |d 950000 |d 950900 |e 910000PB111184576 |e 950000PB111184576 |e 950900PB111184576 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 3 | ||
| 998 | |g 121295591 |a Münter, Marc |m 121295591:Münter, Marc |d 50000 |e 50000PM121295591 |k 0/50000/ |p 2 | ||
| 998 | |g 136129552 |a Jensen, Alexandra |m 136129552:Jensen, Alexandra |p 1 |x j | ||
| 999 | |a KXP-PPN1809113709 |e 4161266634 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Alexandra D. Jensen, Marc W. Münter, Helge G. Bischoff, Renate Haselmann, Uwe Haberkorn, Peter E. Huber, Michael Thomas, Jürgen Debus, and Klaus K. Herfarth"]},"title":[{"title":"Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab","title_sort":"Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab","subtitle":"the Near trial"}],"origin":[{"dateIssuedDisp":"24 January 2011","dateIssuedKey":"2011"}],"id":{"doi":["10.1002/cncr.25888"],"eki":["1809113709"]},"person":[{"given":"Alexandra","family":"Jensen","role":"aut","display":"Jensen, Alexandra"},{"given":"Marc","family":"Münter","display":"Münter, Marc","role":"aut"},{"given":"Helge","role":"aut","display":"Bischoff, Helge","family":"Bischoff"},{"given":"Renate","family":"Haselmann","role":"aut","display":"Haselmann, Renate"},{"given":"Uwe","role":"aut","display":"Haberkorn, Uwe","family":"Haberkorn"},{"family":"Huber","role":"aut","display":"Huber, Peter E.","given":"Peter E."},{"given":"Michael","family":"Thomas","display":"Thomas, Michael","role":"aut"},{"given":"Jürgen","family":"Debus","display":"Debus, Jürgen","role":"aut"},{"family":"Herfarth","display":"Herfarth, Klaus","role":"aut","given":"Klaus"}],"note":["Gesehen am 05.07.2022"],"language":["eng"],"relHost":[{"pubHistory":["1.1948 -"],"language":["eng"],"id":{"doi":["10.1002/(ISSN)1097-0142"],"zdb":["1479932-7"],"issn":["1097-0142"],"eki":["271350334"]},"part":{"volume":"117","extent":"9","issue":"13","pages":"2986-2994","text":"117(2011), 13, Seite 2986-2994","year":"2011"},"origin":[{"dateIssuedDisp":"1948-","publisherPlace":"New York, NY","dateIssuedKey":"1948","publisher":"Wiley-Liss"}],"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}],"disp":"Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab the Near trialCancer","recId":"271350334","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 06.12.2011"],"titleAlt":[{"title":"Cancer cytopathology"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"physDesc":[{"extent":"9 S."}],"recId":"1809113709"} | ||
| SRT | |a JENSENALEXCOMBINEDTR2420 | ||